Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Colorectal Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Nasopharyngeal Carcinoma 1MSI-H 1Lung Neoplasms 1IIIA Stage Non-small Cell Lung Cancer 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Advanced Solid Tumors 1

Interventions

sintilimab 1dacomitinib 1Platinum 1Pemetrexed 1Immune Checkpoint Inhibitors 1Data Collection 1Carboplatin 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Non-small Cell Lung Cancer Metastatic × sintilimab × Clear all
NCT04836728 2025-03-13

CCICC-002b

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Active not recruiting
156 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡